• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

ExThera Medical

DOD chooses ExThera blood filter for COVID-19 trial

June 9, 2020 By Sean Whooley

ExThera Medical announced today that the U.S. Defense Dept. selected its Seraph 100 Microbind affinity blood filter for a U.S.-based clinical trial. The randomized, controlled, multi-center trial will be funded by the DoD and run by investigators at the Uniformed Services University in Bethesda, Md. It comes on the back of encouraging preliminary results in […]

Filed Under: Blood Management, Business/Financial News, Clinical Trials, Featured, Research & Development Tagged With: coronavirus, COVID-19, ExThera Medical, U.S. Department of Defense

ExThera Medical wins CE Mark approval for blood filter

August 7, 2019 By Danielle Kirsh

ExThera Medical yesterday said it received CE Mark approval for is Seraph 100 Microbind Affinity Blood Filter. The Seraph 100 is designed to reduce pathogens during bloodstream infections and the CE Mark allows the filter to be used as an adjunct to anti-infective therapy. ExThera’s filter quickly lowers the concentration of bacteria, viruses and fungi […]

Filed Under: Blood Management Tagged With: ExThera Medical

Exthera Medical wins FDA EAP designation for Seraph 100 blood filter

August 30, 2017 By Fink Densford

Exthera Medical said today that the FDA granted its Seraph 100 blood filter an expedited access pathway designation. The approval comes with an initial indication for use “as an adjunctive treatment for bacteremia in addition to antibiotics for patients receiving hemodialysis when the source of the infection is heparin- or heparin sulfate-binding bacteria, including antibiotic […]

Filed Under: Blood Management, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: ExThera Medical

Exthera Medical closes $15 million Series B for Seraph blood infection filter

June 2, 2016 By MassDevice

Updated to correct funding amounts and include new information from Exthera. By Fink Densford & Varun Saxena Martinez, Calif.-based Exthera Medical said it raised a $15.3 million Series B round following positive tests of its CE-Marked Seraph blood filter in animal studies. The company’s Seraph microbind affinity blood filter is designed to remove a range of sepsis-causing bacteria, […]

Filed Under: Blood Management, Funding Roundup Tagged With: ExThera Medical

ExThera wins nod for CE Mark trial for Seraph blood filter

December 7, 2015 By Brad Perriello

ExThera Medical said it won approval for a CE Mark trial for its Seraph blood filter, which is designed to remove pathogens from the bloodstream. Berkeley, Calif.-based ExThera said Germany’s Bundesinstitut für Arzneimittel und Medizinprodukte approved the protocol for a trial of the Seraph device in treating dialysis patients with Staphylococcus aureus and MRSA bloodstream infections. “Certain bloodstream […]

Filed Under: Blood Management, Dialysis, Hospital Care Tagged With: ExThera Medical

ExThera unveils promising data for ‘superbug’ device

December 8, 2014 By Val Kennedy Leave a Comment

ExThera unveils promising data for 'superbug' device

ExThera Medical unveiled promising data from a study of its Seraph blood-filtering device in the treatment of drug-resistant strains of E. coli and pneumonia.

Filed Under: News Well Tagged With: Clinical Trials, ExThera Medical

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS